Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on QIAGEN NV. We currently have 41 research reports from 6 professional analysts.
Date | Source | Announcement |
---|---|---|
07Jan24 18:03 | DGAP-AHD | EQS-Adhoc: QIAGEN N.V.: QIAGEN zahlt rund 300 Millionen Dollar durch einen synthetischen Aktienrückkauf an seine Aktionärinnen und Aktionäre zurück |
07Jan24 18:03 | DGAP-AHD | EQS-Adhoc: QIAGEN N.V.: QIAGEN to return approximately $300 million to shareholders through a synthetic share repurchase |
03Nov22 21:02 | DGAP-AHD | EQS-DD: Qiagen N.V.: Dr. Metin Colpan, Release of 457 Restricted Stock Units based on grant made on October 31, 2012. Exercise Price: $0.00. Closing price on October 31, 2022: $43.56. Subsequent ... |
03Nov22 21:02 | DGAP-AHD | EQS-DD: Qiagen N.V.: Elizabeth E. Tallett, Release of 457 Restricted Stock Units based on grant made on October 31, 2012. Exercise Price: $0.00. Closing price on October 31, 2022: $43.56. ... |
02Nov22 21:04 | DGAP-AHD | EQS-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution |
02Nov22 21:04 | DGAP-AHD | EQS-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution |
02Nov22 21:04 | DGAP-AHD | EQS-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution |
Share: